Bromide

Bromide

SCHEMBL28667693

Br.CNCCI

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7053928 0.96
Iodide SCHEMBL28654692 0.92
Hydrochloric Acid SCHEMBL28658437 0.92
Sulfuric Acid SCHEMBL28672831 0.78 CA5A (0.33)
SCHEMBL18054741 0.76
SCHEMBL295853 0.74
Bromide SCHEMBL7115005 0.74
Hydrochloric Acid SCHEMBL19922518 0.72
SCHEMBL13634251 0.72
SCHEMBL9882703 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113563255-B Preparation method of remifloxacin intermediate 成都倍特药业股份有限公司 2023-08-18 CN claimed
CN-113563255-A Preparation method of Rifloxacin intermediate 成都倍特药业股份有限公司 2021-10-29 CN claimed
CN-113563255-B Preparation method of remifloxacin intermediate 成都倍特药业股份有限公司 2023-08-18 CN disclosed
CN-113563255-A Preparation method of Rifloxacin intermediate 成都倍特药业股份有限公司 2021-10-29 CN disclosed